Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: genetics – Page 135

Though almost every cell in your body contains a copy of each of your genes, only a small fraction of these genes will be expressed, or turned on. These activations are controlled by specialized snippets of DNA called enhancers, which act like skillful on-off switches. This selective activation allows cells to adopt specific functions in the body, determining whether they become—for example—heart cells, muscle cells, or brain cells.

However, these don’t always turn on the right at the right time, contributing to the development of genetic diseases like cancer and diabetes. A team of Johns Hopkins biomedical engineers has developed a that can predict which enhancers play a role in normal development and disease—an innovation that could someday power the development of enhancer-targeted therapies to treat diseases by turning genes on and off at will. The study results appeared in Nature Genetics.

“We’ve known that enhancers control transitions between for a long time, but what is exciting about this work is that mathematical modeling is showing us how they might be controlled,” said study leader Michael Beer, a professor of biomedical engineering and genetic medicine at Johns Hopkins University.

Read more | >

Reichman University’s new Innovation Institute, which is set to formally open this spring under the auspices of the new Graziella Drahi Innovation Building, aims to encourage interdisciplinary, innovative and applied research as a cooperation between the different academic schools. The establishment of the Innovation Institute comes along with a new vision for the University, which puts the emphasis on the fields of synthetic biology, Artificial Intelligence (AI) and Advanced Reality (XR). Prof. Noam Lemelshtrich Latar, the Head of the Institute, identifies these as fields of the future, and the new Innovation Institute will focus on interdisciplinary applied research and the ramifications of these fields on the subjects that are researched and taught at the schools, for example, how law and ethics influence new medical practices and scientific research.

Synthetic biology is a new interdisciplinary field that integrates biology, chemistry, computer science, electrical and genetic engineering, enabling fast manipulation of biological systems to achieve a desired product.

Prof. Lemelshtrich Latar, with Dr. Jonathan Giron, who was the Institute’s Chief Operating Officer, has made a significant revolution at the University, when they raised a meaningful donation to establish the Scojen Institute for Synthetic Biology. The vision of the Scojen Institute is to conduct applied scientific research by employing top global scientists at Reichman University to become the leading synthetic biology research Institute in Israel. The donation will allow recruiting four world-leading scientists in various scopes of synthetic biology in life sciences. The first scientist and Head of the Scojen Institute has already been recruited – Prof. Yosi Shacham Diamand, a leading global scientist in bio-sensors and the integration of electronics and biology. The Scojen Institute labs will be located in the Graziella Drahi Innovation Building and will be one part of the future Dina Recanati School of Medicine, set to open in the academic year 2024–2025.

Read more | >

A team of scientists led by Masaya Hagiwara of RIKEN national science institute in Japan has developed an ingenious device, using layers of hydrogels in a cube-like structure, that allows researchers to construct complex 3D organoids without using elaborate techniques. The group also recently demonstrated the ability to use the device to build organoids that faithfully reproduce the asymmetric genetic expression that characterizes the actual development of organisms. The device has the potential to revolutionize the way we test drugs, and could also provide insights into how tissues develop and lead to better techniques for growing artificial organs.

Scientists have long struggled to create organoids—organ-like tissues grown in the laboratory—to replicate actual biological development. Creating organoids that function similarly to real tissues is vital for developing medicines since it is necessary to understand how drugs move through various tissues. Organoids also help us gain insights into the process of development itself and are a stepping stone on the way to growing whole organs that can help patients.

Read more | >

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.

Read more | >

A change in just one letter in the code that makes up a cancer-causing gene can significantly affect how aggressive a tumor is or how well a patient with cancer responds to a particular therapy. A new, very precise gene-editing tool created by Weill Cornell Medicine investigators will enable scientists to study the impact of these specific genetic changes in preclinical models rather than being limited to more broadly targeted tactics, such as deleting the entire gene.

The tool was described in a study published Aug. 10 in Nature Biotechnology. Dr. Lukas Dow, an associate professor of biochemistry in medicine at Weill Cornell Medicine, and his colleagues genetically engineered to carry an enzyme that allows the scientists to change a single base or “letter” in the mouse’s genetic code. The enzyme can be turned on or off by feeding the mice an antibiotic called doxycycline, reducing the prospect of unintended genetic changes occurring over time. The tool can also grow miniature versions of intestine, lung, and pancreas tissue called organoids from the mice, enabling even more molecular and biochemical studies of the impact of these precise genetic changes.

“We are excited about using this technology to try and understand the genetic changes that influence a patient’s response to therapies,” said Dr. Dow, who is also a member of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.

Read more | >

Specifically, the researchers examined how THC administered through edibles, a common consumption method, influenced epigenetic changes in crucial areas for fetal development, including the placenta, fetal lung, brain, and heart.

In recent years, the popularity and availability of cannabis has grown significantly, with various consumption methods like edibles gaining traction. However, alongside this trend, there has been a worrisome increase in cannabis use among pregnant women. Unfortunately, our understanding of the detailed effects of using cannabis during pregnancy on the developing child remains limited. Because normal fetal development relies on the crucial process of epigenetic regulation and gene expression modification, it has been suggested that studying the molecular changes linked to cannabis exposure during pregnancy could provide important insights.

To gain a better understanding of the effects of cannabis use during pregnancy, researchers from the Oregon Health & Science University (OHSU) conducted a unique preclinical study that focused on investigating the epigenetic impact of THC, the main active component in cannabis, on fetal development and future health outcomes. The study’s findings were published in the journal Clinical Epigenetics.

With the increasing prevalence of cannabis use, there is a common perception that it is safe. As a result, more pregnant women are turning to cannabis, particularly during the first trimester, to relieve symptoms like morning sickness. However, early pregnancy is a critical time when the developing fetus is most susceptible to environmental factors.

Read more | >

An interdisciplinary team of mathematicians, engineers, physicists, and medical scientists have uncovered an unexpected link between pure mathematics and genetics, that reveals key insights into the structure of neutral mutations and the evolution of organisms.

Number theory, the study of the properties of positive integers, is perhaps the purest form of mathematics. At first sight, it may seem far too abstract to apply to the natural world. In fact, the influential American number theorist Leonard Dickson wrote ‘Thank God that number theory is unsullied by any application.’

And yet, again and again, number theory finds unexpected applications in science and engineering, from leaf angles that (almost) universally follow the Fibonacci sequence, to modern encryption techniques based on factoring prime numbers. Now, researchers have demonstrated an unexpected link between number theory and evolutionary genetics.

Read more | >

Genome editing is a powerful breeding technique that introduces mutations into specific gene sequences in genomes. For genome editing in higher plants, nucleotides for artificial nuclease (e.g. TALEN or CRISPR-Cas9) are transiently or stably introduced into the plant cells. After the introduction of mutations by artificial nucleases, it is necessary to select lines that do not contain the foreign nucleotides to overcome GMO regulation; however, there is still no widely legally authorized and approved method for detecting foreign genes in genome-edited crops. Recently, k-mer analysis based on next-generation sequencing (NGS) was proposed as a new method for detecting foreign DNA in genome-edited agricultural products. Compared to conventional methods, such as PCR and Southern hybridization, in principle, this method can detect short DNA fragments with high accuracy.

Read more | >

The discipline of systems chemistry deals with the analysis and synthesis of various autocatalytic systems and is therefore closely related to the study of the origin of life, since it investigates systems that can be considered as a transition between chemical and biological evolution: more complex than simple molecules, but simpler than living cells.

Tibor Gánti described the theory of self-replicating microspheres as early as 1978. These still lacked , but concealed within their membranes an autocatalytic metabolic network of small molecules, isolated (compartmentalized) within their membranes.

As the autocatalytic process takes place, the membrane-building material is also produced, leading to the division of the sphere. This system may appear to be a , and although it lacks genetic material, this can only be verified experimentally. These microspheres can be considered as “infrabiological” , since they do not reach the level of biological organization, but they exceed the complexity of normal chemical reactions.

Read more | >